These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16780545)

  • 21. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
    Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
    J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of the soluble isoforms of HLA-G.
    Hunt JS; Pace JL; Morales PJ; Ober C
    Mol Hum Reprod; 2003 Nov; 9(11):729-35. PubMed ID: 14561816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific sHLA in healthy donors and donor-specific sHLA in renal transplant patients.
    Borelli SD; Ferreira E; Oliveira AM; Krishnaswamy S; Hiraki DD; Grumet FC
    Hum Immunol; 1999 May; 60(5):430-4. PubMed ID: 10447402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy.
    Luque J; Torres MI; Aumente MD; Marín J; García-Jurado G; González R; Pascual D; Guerra N; López-Rubio F; Alvarez-López MR; Arizón JM; Peña J
    Hum Immunol; 2006; 67(4-5):257-63. PubMed ID: 16720205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of human leucocyte antigen G in peripheral blood of kidney transplantation recipients].
    Xiao L; Shi BY; Cai M; He XY; Xu XG; Han Y; Zhou WQ; Meng XY; Gao Y
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):241-4. PubMed ID: 20356537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
    Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
    Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance of sHLA-G-mediated with better graft acceptance in early posttransplantation.
    Jin HL; Li CR; Xiao L; Shi BY; Cai M; Li ZL; Wang S; Chen LP; Zhan SL; Li PC
    Transplant Proc; 2012 Jun; 44(5):1259-61. PubMed ID: 22663996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients.
    Okushi Y; Okino K; Mukai K; Matsui Y; Hayashi N; Fujimoto K; Adachi H; Yamaya H; Yokoyama H
    Clin Exp Nephrol; 2017 Oct; 21(5):932-940. PubMed ID: 28364323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection.
    Kerman RH; Susskind B; Buelow R; Regan J; Pouletty P; Williams J; Gerolami K; Kerman DH; Katz SM; Van Buren CT; Kahan BD
    Transplantation; 1996 Jul; 62(2):201-5. PubMed ID: 8755816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble HLA class I antigens in pediatric patients with renal transplants from related living donors without acute rejection and treated with triple therapy.
    Tambutti ML; Ferraris JR; Redal MA; Ramirez JA; Prigoshin N
    Hum Immunol; 1996 Oct; 50(2):135-9. PubMed ID: 8891737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation.
    Créput C; Durrbach A; Menier C; Guettier C; Samuel D; Dausset J; Charpentier B; Carosella ED; Rouas-Freiss N
    J Hepatol; 2003 Oct; 39(4):587-94. PubMed ID: 12971970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
    Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation.
    Luque J; Torres MI; Aumente MD; Lozano JM; García-Jurado G; González R; Alvarez-López MR; Arizón JM; Peña J
    Transpl Immunol; 2006 Dec; 17(1):70-3. PubMed ID: 17157221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An association between antibodies specific for endothelial cells and renal transplant failure.
    Perrey C; Brenchley PE; Johnson RW; Martin S
    Transpl Immunol; 1998 Jun; 6(2):101-6. PubMed ID: 9777698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project.
    Ozawa M; Terasaki PI; Lee JH; Castro R; Alberu J; Alonso C; Alvarez I; Toledo R; Alvez H; Monterio M; Teixeira J; Campbell P; Ciszek M; Charron D; Gautreau C; Christiansen F; Conca R; Gomez B; Monteon F; Grosse-Wilde H; Heinemann F; Humar I; Kamoun M; Kimball P; Kobayashi T; Kupatawintu P; Leech S; LeFor W; Mehra N; Panigrahi A; Naumova E; Norman D; Piazza A; Poli F; Colombo B; Roy R; Schonemann C; Sireci G; Tanabe K; Ishida H; Van den Berg-Loonen E; Zeevi A
    Tissue Antigens; 2007 Apr; 69 Suppl 1():174-9. PubMed ID: 17445195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of HLA-G Polymorphisms in the 3'UTR Region and Soluble HLA-G with Kidney Graft Outcome.
    Durmanova V; Bandzuchova H; Zilinska Z; Tirpakova J; Kuba D; Buc M; Polakova K
    Immunol Invest; 2019 Aug; 48(6):644-658. PubMed ID: 31094243
    [No Abstract]   [Full Text] [Related]  

  • 39. [Applications of monitoring human leukocyte antigen G and its inhibitory receptors in post-renal transplantation].
    XIAO L; SHI BY; GAO Y; CAI M; Qian YY; HE XY; XU XG; HAN Y; ZHOU WQ; MENG XY; HAN MX
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(36):2524-7. PubMed ID: 21092455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage.
    Fainardi E; Rizzo R; Lupato A; Ramponi V; De Santis G; Garofano F; Stignani M; Tamborino C; Castellazzi M; Casetta I; Baricordi OR
    Acta Neurochir Suppl; 2010; 106():141-5. PubMed ID: 19812937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.